Singapore markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3800-0.0100 (-0.42%)
At close: 04:00PM EDT
2.3800 0.00 (0.00%)
After hours: 06:06PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.3900
Open2.3900
Bid2.3700 x 1300
Ask2.6000 x 1000
Day's range2.3000 - 2.4600
52-week range2.2800 - 9.4900
Volume2,194,276
Avg. volume2,037,368
Market cap305.128M
Beta (5Y monthly)2.61
PE ratio (TTM)N/A
EPS (TTM)-1.1800
Earnings date31 Oct 2023 - 06 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est9.83
  • Business Wire

    Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    CAMBRIDGE, Mass., September 08, 2023--Seres Therapeutics, Inc. (Nasdaq: MCRB) ("Seres" or the "Company"), a leading microbiome therapeutics company, today announced that on September 6, 2023, the Compensation and Talent Committee of Seres’ board of directors granted inducement equity grants covering an aggregate of 91,000 shares of its common stock to two new employees, consisting of stock options to purchase an aggregate of 45,500 shares of common stock and restricted stock units ("RSUs"), cove

  • Business Wire

    Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

    CAMBRIDGE, Mass., September 07, 2023--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that Seres management will participate at the Morgan Stanley 21st Annual Global Healthcare Conference on Monday, September 11, 2023, at 12:15 p.m. ET.

  • Zacks

    Seres Therapeutics (MCRB) Misses Q2 Earnings Estimates

    Seres Therapeutics (MCRB) delivered earnings and revenue surprises of -34.55% and 0.78%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?